Long Island doctor and son accused of running family-run pill mill
A Long Island doctor and his son have been accused of operating a family-run pill mill by illegally distributing prescription drugs without medical justification. The physician allegedly wrote fraudulent prescriptions for controlled substances without examining patients, while his son helped facilitate sales and collect payments. The pair surrendered to authorities, pleaded not guilty, and face up to five and a half years in prison if convicted.
- ▪Dr. Richard Taubman, a 71-year-old retired obstetrician-gynecologist, and his 33-year-old son Eric Taubman were charged with running a pill mill in New York.
- ▪Between April 5 and June 29, 2022, Dr. Taubman allegedly wrote dozens of prescriptions for drugs like Percocet, Adderall, and Xanax without legitimate medical purpose.
- ▪The prescriptions were written remotely from his home in Glen Head and sent electronically to pharmacies across Queens.
- ▪Pharmacist reports led to the suspension of Dr. Taubman’s prescription license and triggered a multi-year investigation by the DEA and Nassau County authorities.
- ▪The defendants face 23 counts of illegally selling or attempting to sell drug prescriptions and one count of conspiracy, with a potential sentence of up to five and a half years.
Opening excerpt (first ~120 words) tap to expand
Long Island Long Island doctor and son accused of running family-run pill mill By Bonny Chu, Fox News Published May 1, 2026, 2:39 a.m. ET Originally Published by: Eight NYPD officers injured in massive explosion while responding to knife-wielding man in Queens home New York Magazine writer wants to bring back smoking for very nihilistic reasons New York bodega worker killed less than a year after expressing fear to reporter Officials announced Thursday that a doctor and his son have been accused of operating a family-run pill mill in New York, in what authorities describe as a brazen abuse of medical authority to fuel the illegal distribution of prescription drugs.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at New York Post.
Discussion
0 commentsMore from New York Post
